ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography

December 4, 2009

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams

March 30, 2012

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

Other NCI funding opportunities listed.

July 9, 2004

Cancer Letter Editor Finalist for Loeb Award

May 16, 2003